Alvar , J.I.,D.Vélez,P.Desjeux,J.Cano,J.Jannin and M.D. Boer, 2012.Leishmaniasis worldwide and global estimates of its incidence,Plos. one. 7 35671 -35683
Al-Zamel , F.,F. J.Al-Shammary,S.El-Shewemi,R.Soliman, 1996.Enhancement of leishmanicidal activity of human macrophages against Leishmania major and Leishmania donovani infection using recombinant human granulocyte macrophage colony stimulating factor,Zentralbl. Bakteriol 285 92 -105
Armah , H.B.,N.O.Wilson,B.Y.Sarfo,M.D.Powell,V.C.Bond,W.Anderson,A.A.Adjei,R.K.Gyasi,Y.Tettey,E.D.Wiredu,J.E.Tongren,V.Udhayakumar,J.K.Stiles, 2007.Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children,Malar. J 6 -
Azzurri , A.,O.Y.Sow,A.Amedei,B.Bah,S.Diallo,M.Benagiano,M.M. D'Elios , A.,Mantovani and G.,Del Prete, 2005.IFN-gammainducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection,Microbes Infect 7 1 -8
Bail , M.S. and N.J.,Diana, 2007.,Clin. Dermatol 25 203 -211
Choi , C.M.,E.A. , Lerner, 2001.Leishmaniasis as an emerging infection,J. Investig. Dermatol. Symp. Proc. 6 175 -182
Cotterell , S.E.,C.R.Engwerda,P.M.Kaye, 1999.Leishmania donovani infection initiates T cellindependent chemokine re - sponses, which are subsequently amplified in a T-cell dependent manner,Eur. J. Immunol 29 203 -214
Díaz , N.L.,O.Zerpa,F.J.Tapia, 2013.Chemokines and chemokine receptors expression in the lesions of patients with american cutaneous leishmaniasis,Mem Inst Oswaldo Cruz, Rio de Janeiro 108 446 -452
Duthie , M.S.,J.Guderian,A.Vallur,A.Bhatia,P.L.Santos,M.Todt,D.Mondal,R.Almeida,S. G.Reed, 2014.Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment,Eur J Clin Microbiol Infect Dis 33 639 -649
Falconer , K.,G.Askarieh,N.Weis,K.Hellstrand,A.Alaeus,M.Lagging, 2010.-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection,HIV. Scand. J. Infect. Dis 42 896 -901
Fallahi , P.,A.Bonatti, 2016.Leishmaniasis and IFN-gamma dependent chemokines,Clin. Ter 167 e117 -e122
Fatoux-Ardore , M.,F.Peysselona,A.Weissb,P.Bastienc,F.Pratlongc,S.Ricard-Blum, 2013.Large-scale investigation of Leishmania interaction networks with the host extracellular matrix by surface plasmon resonance imaging,Infect. Immun 82 594 -606
Gasperini , S.,M.Marchi,F.Calzetti,C.Laudanna,L.Vicentini,H.Olsen,M.Murphy,F.Liao,J.Farber,M.A.Cassatella, 1999.Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gammainducible protein-10 (IP-10) chemokines by human neutrophils,J. Immunol 162 4928 -4937
Gupta , G., S.,Bhattacharjee , S.,Bhattacharyya , P.,Bhattacharya , A.,Adhikari , A.,Mukherjee , S.B.,Majumdar and S.,Majumdar, 2009.CXC chemokine-mediated protection against visceral leishmaniasis: involvement of the proinflammatory response,JID 200 1300 -1310
Hailu , A.,N.Berhe,P.A.Kager, 2004.Elevated plasma levels of interferon (IFN)-g, IFN-g inducing cytokines, and IFN-g inducible CXC chemokines in visceral leishmaniasis,Am. J. Trop.Med 71 561 -567
Ibarra-Meneses , A.V.,P.Ghosh,F.Hossain,R.Chowdhury,D.Mondal,J.Alvar,J.Moreno,E.Carrillo, 2017.MIG as Biomarkers of Exposure to Leishmania spp., and of Cure in Human Visceral Leishmaniasis,Front. Cell. Infect. Microbiol 7 -
Jones , T. C., 1996.The effect of granulocyte-macrophage colony stimulating factor (rGM-CSF) on macrophage function in microbial disease,Med 13 141 -147
Kitching , A.R.,X.R.Huang,A.L.Turner,P.G.Tipping,A.R.Dunn,S.R.Holdsworth, 2002.The requirement for granulocyte-macrophage colony stimulating factor and granulocyte-colonystimulating factor in leukocyte-mediated immune glomerular injury,J. Am. Soc. Nephrol 13 350 -358
Laudanna , C.,J.Y.Kim,G.Constantin,E.Butcher, 2002.Rapid leukocyte integrin activation by chemokines,Immunol. Rev 186 37 -46
Murray , H.W.,J. S.Cervia,J.Hariprashad,A.P.Taylor,H.Hockman, 1995.Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis,J. Clin. Invest 95 1183 -1192
Naito , T.,H.Yokoyama,K. J.Moore,G.Dranoff,R. C.Mulligan,V. R.Kelley, 1996.Macrophage growth factors introduced into the kidney initiate renal injury,Mol. Med 2 297 -312
Oghumu , S.,C.M.Lezama-Davila,A.P.IsaacMarquez,A.R.Satoskar, 2010.Role of chemokines in regulation of immunity against leishmaniasis,Exp. Parasitol 126 389 -396
Singal , P.,P. P.Singh, 2005.Leishmania donovani amastigote componentsinduced colony-stimulating factors production,Parasitol. Int 54 9 -20
Snider , H., C.,Lezama-Davila , J.,Alexander , and R.,Abhnay, 2009.Sex hormones and modulation of immunity against Leishmaniasis,Nearo. Immuno. Modul 16 106 -133
Teixeira , M.J., C.R.,Teixeira , B.B.,Andrade , M., 2006.Barral-Netto and A. Barral, Chemokines in host-parasite interactions in leishmaniasis,Trends Parasitol 22 32 -40
Vasquez , R.E.,L. Soong,, 2006.CXCL10/gamma interferon-inducible protein 10-mediated protection against Leishmania amazonensis infection in mice,Infect. Immun 74 6769 -6777
World Health Organization, Communicable dise-ases. WHO.C.D.S. (2003).
World HealthOrganization, 2010.Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases (, -